{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:16:06Z","timestamp":1791832566389,"version":"4.3.4"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0145719","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T14:35:38Z","timestamp":1453732538000},"page":"e0145719","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial"],"prefix":"10.1371","volume":"11","author":[{"given":"Ruben N.","family":"Eppinga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minke H. T.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P. H.","family":"Lexis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margery A.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Lipsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwan C. C.","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim","family":"van der Harst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin P. F.","family":"Dullaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"C Baigent","year":"2010","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)","volume":"33","author":"J Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"ref3","first-page":"19","article-title":"Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function","volume":"109","author":"HJ Kempen","year":"1987","journal-title":"J Lab Clin Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.ATV.18.7.1046","article-title":"Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease","volume":"18","author":"DS Freedman","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0002-9149(02)02427-X","article-title":"Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial","volume":"90","author":"RS Rosenson","year":"2002","journal-title":"Am J Cardiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1373\/clinchem.2010.155333","article-title":"HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events","volume":"57","author":"RS Rosenson","year":"2011","journal-title":"Clin Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e56782","DOI":"10.1371\/journal.pone.0056782","article-title":"Levels of cholesterol in small LDL particles predict atherosclerosis progression and incident CHD in the HDL-Atherosclerosis Treatment Study (HATS)","volume":"8","author":"PT Williams","year":"2013","journal-title":"PloS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.atherosclerosis.2014.05.914","article-title":"Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets","volume":"235","author":"PP Toth","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref9","article-title":"Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies","author":"PH Joshi","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1161\/CIRCRESAHA.114.302805","article-title":"Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndrome","volume":"114","author":"RS Rosenson","year":"2014","journal-title":"Circ Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","article-title":"High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis)","volume":"60","author":"RH Mackey","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/CIRCULATIONAHA.111.073684","article-title":"Lipids and lipoproteins and risk of different vascular events in the MRC\/BHF Heart Protection Study","volume":"125","author":"S Parish","year":"2012","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.113.002671","article-title":"High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy","volume":"128","author":"S Mora","year":"2013","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacl.2011.02.001","article-title":"Clinical implications of discordance between low-density lipoprotein cholesterol and particle number","volume":"5","author":"JD Otvos","year":"2011","journal-title":"J Clin Lipidol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2006.09.043","article-title":"Value of Low-Density Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study","volume":"49","author":"K El Harchaoui","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein Particle Analysis by Nuclear Magnetic Resonance Spectroscopy","volume":"26","author":"EJ Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/CIRCULATIONAHA.108.816181","article-title":"Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women","volume":"119","author":"S Mora","year":"2009","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2006.05.007","article-title":"LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"192","author":"S Mora","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2337\/dc08-9018","article-title":"Lipoprotein Management in Patients With Cardiometabolic Risk Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation","volume":"31","author":"JD Brunzell","year":"2008","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-2362.2010.02357.x","article-title":"Lipid assessment, metabolic syndrome and coronary heart disease risk","volume":"40","author":"BJ Arsenault","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.113.005873","article-title":"Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events","volume":"129","author":"S Mora","year":"2014","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2013-1452","article-title":"Lifestyle and Metformin Treatment Favorably Influence Lipoprotein Subfraction Distribution in the Diabetes Prevention Program","volume":"98","author":"R Goldberg","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S2213-8587(13)70152-9","article-title":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial","volume":"2","author":"D Preiss","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1475-2840-13-73","article-title":"Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function","volume":"13","author":"D Trifunovic","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.ijcard.2013.12.207","article-title":"Insulin resistance and short-term mortality in patients with acute myocardial infarction","volume":"172","author":"R Sanjuan","year":"2014","journal-title":"Int J Cardiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10557-012-6413-1","article-title":"Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial","volume":"26","author":"CPH Lexis","year":"2012","journal-title":"Cardiovasc Drugs Ther Spons Int Soc Cardiovasc Pharmacother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.2014.3315","article-title":"Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial","volume":"311","author":"CPH Lexis","year":"2014","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/07853890.2012.679962","article-title":"Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study","volume":"45","author":"N Oksala","year":"2012","journal-title":"Ann Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00330-012-2420-7","article-title":"The role of cardiac magnetic resonance imaging following acute myocardial infarction","volume":"22","author":"DTL Wong","year":"2012","journal-title":"Eur Radiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.97.23.2302","article-title":"Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group","volume":"97","author":"AW Van \u2018t Hof","year":"1998","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2362.1978.tb00824.x","article-title":"Variations in apolipoproteins B and A, during the course of myocardial infarction","volume":"8","author":"P Avogaro","year":"1978","journal-title":"Eur J Clin Invest"},{"key":"ref32","first-page":"A6006","article-title":"[Revised Dutch College of General Practitioners\u2019 practice guideline \u201cAcute coronary syndrome\u201d]","volume":"157","author":"M Bouma","year":"2013","journal-title":"Ned Tijdschr Geneeskd"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00365510151067866","article-title":"Plasma cholesteryl ester transfer and hepatic lipase activity are related to high-density lipoprotein cholesterol in association with insulin resistance in type 2 diabetic and non-diabetic subjects","volume":"61","author":"SC Riemens","year":"2001","journal-title":"Scand J Clin Lab Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCGENETICS.111.960575","article-title":"Effect of heparin administration on metabolomic profiles in samples obtained during cardiac catheterization","volume":"4","author":"MP Brunner","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"S Lewington","year":"2007","journal-title":"Lancet Lond Engl"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"MAjor lipids, apolipoproteins, and risk of vascular disease","volume":"302","year":"2009","journal-title":"JAMA"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jacl.2014.11.003","article-title":"High-density lipoprotein subfractions in relation with the severity of coronary artery disease: A Gensini score assessment","volume":"9","author":"R-X Xu","year":"2015","journal-title":"J Clin Lipidol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/eurheartj\/ehi186","article-title":"High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial","volume":"26","author":"AG Olsson","year":"2005","journal-title":"Eur Heart J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.atherosclerosis.2014.02.026","article-title":"Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: implications for cardiac outcome","volume":"234","author":"RPF Dullaart","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2014.02.026","article-title":"The HDL anti-inflammatory function is impaired in myocardial infarction and may predict new cardiac events independent of HDL cholesterol","volume":"433","author":"RPF Dullaart","year":"2014","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"AV Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/bmm.13.35","article-title":"Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research","volume":"7","author":"M Triolo","year":"2013","journal-title":"Biomark Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.109.830984","article-title":"Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study","volume":"120","author":"RS Velagaleti","year":"2009","journal-title":"Circulation"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/gt.2013.30","article-title":"Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice","volume":"20","author":"SC Gordts","year":"2013","journal-title":"Gene Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/eurheartj\/ehu171","article-title":"Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial","volume":"35","author":"J-C Tardif","year":"2014","journal-title":"Eur Heart J"},{"key":"ref46","first-page":"3761","article-title":"Variability in lipid profile among patients presented with acute myocardial infarction, unstable angina and stable angina pectoris","volume":"18","author":"N Yang","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.amjcard.2014.09.015","article-title":"Impact of acute and chronic hyperglycemia on in-hospital outcomes of patients with acute myocardial infarction","volume":"114","author":"M Fujino","year":"2014","journal-title":"Am J Cardiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0145719","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:30:10Z","timestamp":1540333810000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0145719"}},"subtitle":[],"editor":[{"given":"Giacomo","family":"Frati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0145719","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]}}}